Thursday , 7 November 2024
Home FDA Approval

FDA Approval

Novavax vaccine
Healthcare

FDA Approves Novavax COVID Vaccine After Pfizer and Moderna

On Friday, the Food and Drug Administration (FDA) granted approval for an updated COVID-19 vaccine developed by Novavax, following the previous week’s endorsement...

injection pen for diabetic
Healthcare

Ozempic and Wegovy: Weight Loss to Heart Health

Drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound, initially developed for weight loss and diabetes management, are now being investigated for their potential...

Eli Lilly
Healthcare

FDA Greenlights Eli Lilly’s Alzheimer’s Drug Donanemab

On Tuesday, the Food and Drug Administration (FDA) granted approval for Eli Lilly’s Alzheimer’s drug, donanemab, marking a significant milestone in the treatment...

NJOY
Healthcare

FDA Approves Menthol Vapes Amid Cigarette Ban Delays

On Friday, the Food and Drug Administration (FDA) approved the first-ever menthol-flavored vapes, allowing four NJOY menthol e-cigarettes to enter the market. NJOY,...

Mifepristone
Policy

Supreme Court Upholds Mifepristone for Abortion

The Supreme Court has upheld the approval of the abortion drug mifepristone, ruling that challengers seeking to restrict the medication lack the legal...

PD-1 Antibody Targeting Immune Checkpoint Inhibition
Healthcare

Cancer Treatment’s New Hope: Checkpoint Inhibitors

Two decades ago, patients with aggressive cancers faced grim prognoses, as treatment options were limited. However, a paradigm shift occurred with the introduction...

Eli Lilly
Healthcare

Eli Lilly’s Zepbound Reduces Sleep Apnea in Obese Adults

Eli Lilly’s Zepbound, a weight loss drug, showed promise in treating sleep apnea in obese adults, the company announced Wednesday. Results from late-stage...

Amylyx Pharmaceuticals
Healthcare

ALS Drug Relyvrio Withdrawn Due to Ineffectiveness

Amylyx Pharmaceuticals has decided to withdraw its ALS drug Relyvrio from the market following disappointing results from a phase III trial. The drug,...